-
-
-
-
-
-
-
Soligenix receives EU orphan drug status for Behçet's disease treatment
-
-
-
-
-
-
-
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
-
-
-
-
-
-
-
Soligenix featured in editorial on rare disease therapy development
-
-
-
-
-
-
-
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
-
-
-
-
-
-
-
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
-
-
-
-
-
448,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

